SCHEDULE 13G/A: Brandes Investment Partners Discloses Passive Stake in Phibro Animal Health Corporation

Brandes Investment Partners and affiliated entities have disclosed a passive beneficial ownership of 3.26% in Phibro Animal Health Corporation's common stock as of December 31, 2024.

Summary

• Brandes Investment Partners, L.P., along with CO-GP, LLC, Brandes Worldwide Holdings, L.P., and Glenn Carlson, collectively reported beneficial ownership of 662,748 shares of Phibro Animal Health Corporation's Common Stock.
• This aggregate ownership represents 3.26% of the class of securities.
• The filing, an Amendment No. 2 to Schedule 13G, indicates that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• The reporting persons hold shared voting power over 662,440 shares and shared dispositive power over 662,748 shares, with no sole voting or dispositive power.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment as it does not contain performance data, forward-looking statements, or strategic updates.

Future Outlook

NA

Industry Context

This filing is a routine disclosure by an institutional investor regarding its passive ownership stake in a publicly traded company within the animal health sector. It does not provide specific insights into broader industry trends or competitive dynamics beyond the ownership structure.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive ownership stakes, which can influence perceptions of institutional interest and stability in the company's stock.

Key Dates

Keywords

Phibro Animal Health Corporation, Brandes Investment Partners, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investor, passive stake